Geneos Wealth Management’s CyrusOne Inc Common Stock CONE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-71
| Closed | -$6K | – | 3064 |
|
|
2021
Q4 | $6K | Sell |
71
-350
| -83% | -$29.7K | ﹤0.01% | 2385 |
|
|
2021
Q3 | $32K | Buy |
421
+1
| +0.2% | +$75 | ﹤0.01% | 1705 |
|
|
2021
Q2 | $29K | Sell |
420
-2
| -0.5% | -$146 | ﹤0.01% | 1740 |
|
|
2021
Q1 | $30K | Buy |
422
+2
| +0.5% | +$139 | ﹤0.01% | 1886 |
|
|
2020
Q4 | $28K | Buy |
420
+350
| +500% | +$25.4K | ﹤0.01% | 1741 |
|
|
2020
Q3 | $5K | Hold |
70
| – | – | ﹤0.01% | 2218 |
|
|
2020
Q2 | $5K | Sell |
70
-25
| -26% | -$1.78K | ﹤0.01% | 2184 |
|
|
2020
Q1 | $5K | Hold |
95
| – | – | ﹤0.01% | 2070 |
|
|
2019
Q4 | $6K | Hold |
95
| – | – | ﹤0.01% | 2161 |
|
|
2019
Q3 | $7K | Hold |
95
| – | – | ﹤0.01% | 2037 |
|
|
2019
Q2 | $5K | Hold |
95
| – | – | ﹤0.01% | 2140 |
|
|
2019
Q1 | $4K | Buy |
95
+5
| +6% | +$262 | ﹤0.01% | 2124 |
|
|
2018
Q4 | $4K | Hold |
90
| – | – | ﹤0.01% | 2085 |
|
|
2018
Q3 | $5K | Hold |
90
| – | – | ﹤0.01% | 2089 |
|
|
2018
Q2 | $5K | Hold |
90
| – | – | ﹤0.01% | 1946 |
|
|
2018
Q1 | $4K | Hold |
90
| – | – | ﹤0.01% | 1928 |
|
|
2017
Q4 | $5K | Hold |
90
| – | – | ﹤0.01% | 1846 |
|
|
2017
Q3 | $5K | Hold |
90
| – | – | ﹤0.01% | 1782 |
|
|
2017
Q2 | $5K | Hold |
90
| – | – | ﹤0.01% | 1751 |
|
|
2017
Q1 | $4K | Sell |
90
-25
| -22% | -$1.23K | ﹤0.01% | 1774 |
|
|
2016
Q4 | $5K | Hold |
115
| – | – | ﹤0.01% | 1666 |
|
|
2016
Q3 | $5K | Buy |
115
+25
| +28% | +$1.29K | ﹤0.01% | 1606 |
|
|
2016
Q2 | $4K | Hold |
90
| – | – | ﹤0.01% | 1597 |
|
|
2016
Q1 | $4K | Buy |
+90
| New | +$3.44K | ﹤0.01% | 1578 |
|
Other funds holding CONE
Geneos Wealth Management's CONE Position: Q1 2022 in Review
Geneos Wealth Management sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 71 shares — an estimated $6K sold.
Geneos Wealth Management first reported a position in CONE in Q1 2016 and held it in 24 quarters. The position peaked at $32K in Q3 2021. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.
- Geneos Wealth Management reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
- Geneos Wealth Management sold 71 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $6K.
- Geneos Wealth Management first reported a position in CyrusOne Inc Common Stock in Q1 2016 and held it in 24 quarters.
- Geneos Wealth Management's CyrusOne Inc Common Stock position peaked at $32K in Q3 2021.
- 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.
Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.